Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

Am J Ophthalmol. 1999 Oct;128(4):509-10. doi: 10.1016/s0002-9394(99)00196-8.

Abstract

Purpose: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.

Methods: Review of in vitro sensitivities of all ocular isolates of P. aeruginosa be tween July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more microg per ml.

Results: Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/ 196) of ocular isolates showed in vitro resistance (P = .014).

Conclusions: Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern.

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Ciprofloxacin / therapeutic use*
  • Drug Resistance, Microbial
  • Eye / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification

Substances

  • Anti-Infective Agents
  • Ciprofloxacin